3Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
4Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
7Tobe K, Ogura T, Tsukamoto G. Relationship between serum Leptin and fatty liver in Japanese adoloescet university students. Am J Gastroenterol,1999,94(3) :328 - 3 335
8Adachi Y, Bradford BU, Gao W, et al. Inactivation of Kuffer cells prevent early alcohol-induced liver injury. Hepatology, 1994,34(20) :453 - 460
9king NA,Tremblay A.Effects of exercise on appetite Control [J].Med Sci Spor Exerc， 1997， 29:1076－ 1089
10GwirtzPA Brandt MA,Mass HJ etal.Endurance trainjing altaer arterial baroreflex function in dog [J].Med Sic Sport Exerc,1990,22:200 － 206
9Chobanian AV,Bakris GL,Black HR,et al.The seventhreport of the Joint National Committee on prevention,detec-tion,evaluation,and treatment of high blood pressure theJNC7[J].JAMA,2003,289(19):2560-2571.
10Greenlund K J,Croft JB,Mensah GA.Prevalence of heartof disease and stroke risk factors in persons with prehyper-tension in the United States,1999-2000[J].Archives of In-ternal Medicine,2004,164(19):2113-2118.
